These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6849732)

  • 1. Effect of inhibitors of prostaglandin synthesis on hepatic drug clearance.
    Feely J; Wood AJ
    Br J Clin Pharmacol; 1983 Jan; 15(1):109-11. PubMed ID: 6849732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
    Roberts CJ; Jackson L; Halliwell M; Branch RA
    Br J Clin Pharmacol; 1976 Oct; 3(5):907-13. PubMed ID: 973986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
    Bauer LA; Stenwall M; Horn JR; Davis R; Opheim K; Greene L
    Clin Pharmacol Ther; 1986 Aug; 40(2):239-42. PubMed ID: 3731687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
    Branch RA; James JA; Read AE
    Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
    Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG
    Clin Pharmacol Ther; 1979 Jul; 26(1):16-20. PubMed ID: 445957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of isolated hepatic ischemia on organic anion clearance and oxidative metabolism.
    Minard G; Bynoe R; Wood GC; Fabian TC; Croce M; Kudsk KA
    J Trauma; 1992 Apr; 32(4):514-8; discussion 518-9. PubMed ID: 1569625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous administration of multiple model substrates to assess hepatic drug clearance.
    Crom WR; Webster SL; Bobo L; Teresi ME; Relling MV; Evans WE
    Clin Pharmacol Ther; 1987 Jun; 41(6):645-50. PubMed ID: 3581648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy.
    Relling MV; Crom WR; Pieper JA; Cupit GC; Rivera GK; Evans WE
    Clin Pharmacol Ther; 1987 Jun; 41(6):651-60. PubMed ID: 3472701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man.
    Daneshmend TK; Ene MD; Parker G; Roberts CJ
    Gut; 1984 Feb; 25(2):125-8. PubMed ID: 6693040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Beppu T; Sugiura M; Sanjo K; Idezuki Y
    Clin Pharmacol Ther; 1988 Aug; 44(2):217-24. PubMed ID: 3396264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the effects of labetalol, verapamil and diltiazem on antipyrine and indocyanine green clearances.
    Rocci ML; Vlasses PH; Lener ME; Fruncillo RA; Sirgo MA
    J Clin Pharmacol; 1989 Oct; 29(10):891-5. PubMed ID: 2592580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of prostaglandin inhibition on calcium excretion in normal volunteers.
    Rocco VK; Sakhaee K; Pak CY; Brater DC
    J Urol; 1985 Jun; 133(6):1093-4. PubMed ID: 3999216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Breimer DD; Zilly W; Richter E
    Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prostaglandin inhibition by indomethacin on renal function in alcoholic versus non-alcoholic cirrhotic patients.
    Kawasaki H; Murawaki Y; Ohtake H; Hirayama C
    Gastroenterol Jpn; 1983 Aug; 18(4):314-9. PubMed ID: 6414873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on apparent liver blood flow of histamine-receptor blockers and inhibition of prostaglandin synthesis.
    Feely J; Wood AJ
    Clin Pharmacol Ther; 1983 Jan; 33(1):91-4. PubMed ID: 6129092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neurotrauma on hepatic drug clearance.
    Boucher BA; Kuhl DA; Fabian TC; Robertson JT
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):487-97. PubMed ID: 1934861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1978 Oct; 60(4):313-8. PubMed ID: 714726
    [No Abstract]   [Full Text] [Related]  

  • 18. The features of hepatic enzyme induction with glutethimide in man.
    Jackson L; Homeida M; Roberts CJ
    Br J Clin Pharmacol; 1978 Dec; 6(6):525-8. PubMed ID: 728322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic drug clearance in patients with mild cystic fibrosis.
    Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
    Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
    Traeger A; Horváth T; Rechenbach C; Jávor T
    Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.